Full View

ING5 inhibits migration and invasion of esophageal cancer cells by downregulating the IL-6/CXCL12 signaling pathway

Y Wang, J Tan, J Li, H Chen… - Technology in Cancer …, 2021 - journals.sagepub.com
Esophageal squamous cell carcinoma (ESCC) is a common cancer in East Asia and in other
parts of the world and exhibits a poor prognosis. Growth inhibitor 5 (ING5) is a new member …
被引用次数：8 相关文章

ING5 Inhibits Migration and Invasion of Esophageal Cancer Cells by Downregulating the IL-6/CXCL12 Signaling Pathway.

Y Wang, J Tan, J Li, H Chen… - Technology in Cancer …, 2021 - search.ebscohost.com
Esophageal squamous cell carcinoma (ESCC) is a common cancer in East Asia and in other
parts of the world and exhibits a poor prognosis. Growth inhibitor 5 (ING5) is a new member …

ING5 Inhibits Migration and Invasion of Esophageal Cancer Cells by Downregulating the IL-6/CXCL12 Signaling Pathway.

Y Wang, J Tan, J Li, H Chen, W Wang - Technology in Cancer …, 2021 - europepmc.org
Esophageal squamous cell carcinoma (ESCC) is a common cancer in East Asia and in other
parts of the world and exhibits a poor prognosis. Growth inhibitor 5 (ING5) is a new member …
[HTML] nih.gov

[HTML][HTML] ING5 Inhibits Migration and Invasion of Esophageal Cancer Cells by Downregulating the IL-6/CXCL12 Signaling Pathway

Y Wang, J Tan, J Li, H Chen… - Technology in Cancer …, 2021 - ncbi.nlm.nih.gov
Esophageal squamous cell carcinoma (ESCC) is a common cancer in East Asia and in other
parts of the world and exhibits a poor prognosis. Growth inhibitor 5 (ING5) is a new member …

ING5 Inhibits Migration and Invasion of Esophageal Cancer Cells by Downregulating the IL-6/CXCL12 Signaling Pathway

Y Wang, J Tan, J Li, H Chen… - Technology in cancer …, 2021 - pubmed.ncbi.nlm.nih.gov
Esophageal squamous cell carcinoma (ESCC) is a common cancer in East Asia and in other
parts of the world and exhibits a poor prognosis. Growth inhibitor 5 (ING5) is a new member …